Skip to main content
Erschienen in: World Journal of Surgery 6/2014

01.06.2014

Quality of Life After Surgical Treatment of Early Barrett’s Cancer: A Prospective Comparison of the Ivor-Lewis Resection Versus the Modified Merendino Resection

verfasst von: Ch. Zapletal, Ch. Heesen, J. Origer, M. Pauthner, O. Pech, Ch. Ell, Dietmar Lorenz

Erschienen in: World Journal of Surgery | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The Merendino (MER) procedure has been evaluated as an alternative to transthoracic esophageal resection (TER) for early stage Barrett’s carcinoma. Apart from reducing morbidity and mortality, improvements concerning postoperative health-related quality of life (HRQL) have been postulated. The aim of our study was to compare HRQL between these procedures.

Materials and methods

Between July 2000 and July 2007, 117 patients with early Barrett’s carcinoma underwent surgery. Patients with tumor recurrence were excluded from the study. HRQL was assessed 1 and 2 years after surgery using the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire (EORTC-QLQ-C30) and the QLQ-OES18 module. Patients recently diagnosed with early Barrett’s carcinoma served as controls. Symptoms that showed a difference of more than ten between the control and the study groups were considered clinically relevant and were tested for significant differences between the study groups using the Mann–Whitney U test (p < 0.05).

Results

The response rates for the questionnaires ranged between 70 and 93 %. In the MER group, more items reflected a clinical relevant impairment of HRQL than in the TER group. Significant complaints in the MER group included nausea/vomiting, appetite loss, local pain, difficulties with social eating, and choking. Moreover, we found a significant restriction concerning global health and emotional and social functioning in this group 1 year after surgery. 2 years postoperatively, hardly any differences between the operative techniques could be detected. The only symptom in favor of the MER procedure was a better dysphagia score postoperatively.

Conclusion

Our study suggests that MER procedure is not superior to subtotal esophagectomy with regard to HRQL.
Literatur
1.
Zurück zum Zitat Jemal A, Murray T, Ward E et al (2005) Cancer statistics. CA Cancer J Clin 1:10–30CrossRef Jemal A, Murray T, Ward E et al (2005) Cancer statistics. CA Cancer J Clin 1:10–30CrossRef
2.
Zurück zum Zitat Buttar NS, Wang KK, Sebo TJ et al (2001) Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology 7:1630–1639CrossRef Buttar NS, Wang KK, Sebo TJ et al (2001) Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology 7:1630–1639CrossRef
3.
Zurück zum Zitat Aldulaimi DM, Cox M, Nwokolo CU et al (2005) Barrett’s surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival. Eur J Gastroenterol Hepatol 9:943–950CrossRef Aldulaimi DM, Cox M, Nwokolo CU et al (2005) Barrett’s surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival. Eur J Gastroenterol Hepatol 9:943–950CrossRef
4.
Zurück zum Zitat Fountoulakis A, Zafirellis KD, Dolan K et al (2004) Effect of surveillance of Barrett’s oesophagus on the clinical outcome of oesophageal cancer. Br J Surg 8:997–1003CrossRef Fountoulakis A, Zafirellis KD, Dolan K et al (2004) Effect of surveillance of Barrett’s oesophagus on the clinical outcome of oesophageal cancer. Br J Surg 8:997–1003CrossRef
5.
Zurück zum Zitat Jamieson GG, Mathew G, Ludemann R et al (2004) Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 8:943–947CrossRef Jamieson GG, Mathew G, Ludemann R et al (2004) Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 8:943–947CrossRef
6.
Zurück zum Zitat Viklund P, Lindblad M, Lu M et al (2006) Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg 2:204–211CrossRef Viklund P, Lindblad M, Lu M et al (2006) Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg 2:204–211CrossRef
7.
Zurück zum Zitat Scarpa M, Valente S, Alfieri R et al (2011) Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World J Gastroenterol 42:4660–4674CrossRef Scarpa M, Valente S, Alfieri R et al (2011) Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World J Gastroenterol 42:4660–4674CrossRef
8.
Zurück zum Zitat Scarpa M, Saadeh LM, Fasolo A et al (2013) Health-related quality of life in patients with oesophageal cancer: analysis at different steps of the treatment pathway. J Gastrointest Surg 3:421–433CrossRef Scarpa M, Saadeh LM, Fasolo A et al (2013) Health-related quality of life in patients with oesophageal cancer: analysis at different steps of the treatment pathway. J Gastrointest Surg 3:421–433CrossRef
9.
Zurück zum Zitat Tatematsu N, Hasegawa S, Tanaka E et al (2013) Impact of oesophagectomy on physical fitness and health-related quality of life in patients with oesophageal cancer. Eur J Cancer Care (Engl) 22(3):308–313CrossRef Tatematsu N, Hasegawa S, Tanaka E et al (2013) Impact of oesophagectomy on physical fitness and health-related quality of life in patients with oesophageal cancer. Eur J Cancer Care (Engl) 22(3):308–313CrossRef
10.
Zurück zum Zitat Chennat J, Konda VJA, Ross AS et al (2009) Complete Barrett’s eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma: an American single-center experience. Am J Gastroenterol 11:2684–2692CrossRef Chennat J, Konda VJA, Ross AS et al (2009) Complete Barrett’s eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma: an American single-center experience. Am J Gastroenterol 11:2684–2692CrossRef
11.
Zurück zum Zitat Dunbar KB, Spechler SJ (2012) The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol 6:850–862 quiz 863CrossRef Dunbar KB, Spechler SJ (2012) The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol 6:850–862 quiz 863CrossRef
12.
Zurück zum Zitat Pech O, Behrens A, May A et al (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 9:1200–1206CrossRef Pech O, Behrens A, May A et al (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 9:1200–1206CrossRef
13.
Zurück zum Zitat Pech O, Bollschweiler E, Manner H et al (2011) Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg 1:67–72CrossRef Pech O, Bollschweiler E, Manner H et al (2011) Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg 1:67–72CrossRef
14.
Zurück zum Zitat Omloo JMT, Lagarde SM, Hulscher JBF et al (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 6:992–1000 discussion 1000–1001CrossRef Omloo JMT, Lagarde SM, Hulscher JBF et al (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 6:992–1000 discussion 1000–1001CrossRef
15.
Zurück zum Zitat Stein HJ, Feith M, Mueller J et al (2000) Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann Surg 6:733–742CrossRef Stein HJ, Feith M, Mueller J et al (2000) Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann Surg 6:733–742CrossRef
16.
Zurück zum Zitat Merendino KA, Dillard DH (1955) The concept of sphincter substitution by an interposed jejunal segment for anatomic and physiologic abnormalities at the esophagogastric junction; with special reference to reflux esophagitis, cardiospasm and esophageal varices. Ann Surg 3:486–506CrossRef Merendino KA, Dillard DH (1955) The concept of sphincter substitution by an interposed jejunal segment for anatomic and physiologic abnormalities at the esophagogastric junction; with special reference to reflux esophagitis, cardiospasm and esophageal varices. Ann Surg 3:486–506CrossRef
17.
Zurück zum Zitat Gerzic ZB (1997) Modification of the Merendino procedure. Dis Esophagus 4:270–275 Gerzic ZB (1997) Modification of the Merendino procedure. Dis Esophagus 4:270–275
18.
Zurück zum Zitat Gaissert HA, Mathisen DJ, Grillo HC et al (1993) Short-segment intestinal interposition of the distal esophagus. J Thorac Cardiovasc Surg 5:860–866 discussion 866–867 Gaissert HA, Mathisen DJ, Grillo HC et al (1993) Short-segment intestinal interposition of the distal esophagus. J Thorac Cardiovasc Surg 5:860–866 discussion 866–867
19.
Zurück zum Zitat Picchio M, Lombardi A, Zolovkins A et al (1997) Jejunal interposition for peptic stenosis of the esophagus following esophagomyotomy for achalasia. Int Surg 2:198–200 Picchio M, Lombardi A, Zolovkins A et al (1997) Jejunal interposition for peptic stenosis of the esophagus following esophagomyotomy for achalasia. Int Surg 2:198–200
20.
Zurück zum Zitat Parameswaran R, McNair A, Avery KNL et al (2008) The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review. Ann Surg Oncol 9:2372–2379CrossRef Parameswaran R, McNair A, Avery KNL et al (2008) The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review. Ann Surg Oncol 9:2372–2379CrossRef
21.
Zurück zum Zitat Bennett C, Vakil N, Bergman J et al (2012) Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 2:336–346CrossRef Bennett C, Vakil N, Bergman J et al (2012) Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 2:336–346CrossRef
22.
Zurück zum Zitat Pech O, May A, Rabenstein T et al (2007) Endoscopic resection of early oesophageal cancer. Gut 11:1625–1634CrossRef Pech O, May A, Rabenstein T et al (2007) Endoscopic resection of early oesophageal cancer. Gut 11:1625–1634CrossRef
23.
Zurück zum Zitat Ando S, Tsuji H (2008) Surgical technique of vagus nerve-preserving gastrectomy with D2 lymphadenectomy for gastric cancer. ANZ J Surg 3:172–176CrossRef Ando S, Tsuji H (2008) Surgical technique of vagus nerve-preserving gastrectomy with D2 lymphadenectomy for gastric cancer. ANZ J Surg 3:172–176CrossRef
24.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 5:365–376CrossRef Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 5:365–376CrossRef
25.
Zurück zum Zitat Blazeby JM, Conroy T, Hammerlid E et al (2003) Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 10:1384–1394CrossRef Blazeby JM, Conroy T, Hammerlid E et al (2003) Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 10:1384–1394CrossRef
26.
Zurück zum Zitat Fayers PM (2008) Evaluating the effectiveness of using PROs in clinical practice: a role for cluster-randomised trials. Qual Life Res 10:1315–1321CrossRef Fayers PM (2008) Evaluating the effectiveness of using PROs in clinical practice: a role for cluster-randomised trials. Qual Life Res 10:1315–1321CrossRef
27.
Zurück zum Zitat Viklund P, Wengström Y, Rouvelas I et al (2006) Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer 10:1407–1414CrossRef Viklund P, Wengström Y, Rouvelas I et al (2006) Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer 10:1407–1414CrossRef
28.
Zurück zum Zitat Osoba D, Rodrigues G, Myles J et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1:139–144 Osoba D, Rodrigues G, Myles J et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1:139–144
29.
Zurück zum Zitat King MT (1996) The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 6:555–567CrossRef King MT (1996) The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 6:555–567CrossRef
30.
Zurück zum Zitat de Boer AGEM, van Lanschot JJB, van Sandick JW et al (2004) Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 20:4202–4208CrossRef de Boer AGEM, van Lanschot JJB, van Sandick JW et al (2004) Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 20:4202–4208CrossRef
31.
Zurück zum Zitat Blazeby JM, Farndon JR, Donovan J et al (2000) A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 8:1781–1787CrossRef Blazeby JM, Farndon JR, Donovan J et al (2000) A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 8:1781–1787CrossRef
32.
Zurück zum Zitat Moraca RJ, Low DE (2006) Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch Surg 6:545–549 discussion 549–551CrossRef Moraca RJ, Low DE (2006) Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch Surg 6:545–549 discussion 549–551CrossRef
33.
Zurück zum Zitat Parameswaran R, Blazeby JM, Hughes R et al (2010) Health-related quality of life after minimally invasive oesophagectomy. Br J Surg 4:525–531CrossRef Parameswaran R, Blazeby JM, Hughes R et al (2010) Health-related quality of life after minimally invasive oesophagectomy. Br J Surg 4:525–531CrossRef
34.
Zurück zum Zitat Rutegård M, Lagergren J, Rouvelas I et al (2008) Population-based study of surgical factors in relation to health-related quality of life after oesophageal cancer resection. Br J Surg 5:592–601CrossRef Rutegård M, Lagergren J, Rouvelas I et al (2008) Population-based study of surgical factors in relation to health-related quality of life after oesophageal cancer resection. Br J Surg 5:592–601CrossRef
35.
Zurück zum Zitat Barbour AP, Lagergren P, Hughes R et al (2008) Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. Br J Surg 1:80–84 Barbour AP, Lagergren P, Hughes R et al (2008) Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. Br J Surg 1:80–84
36.
Zurück zum Zitat Djärv T, Lagergren J, Blazeby JM et al (2008) Long-term health-related quality of life following surgery for oesophageal cancer. Br J Surg 9:1121–1126CrossRef Djärv T, Lagergren J, Blazeby JM et al (2008) Long-term health-related quality of life following surgery for oesophageal cancer. Br J Surg 9:1121–1126CrossRef
37.
Zurück zum Zitat Lagergren P, Avery KNL, Hughes R et al (2007) Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer 3:686–693CrossRef Lagergren P, Avery KNL, Hughes R et al (2007) Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer 3:686–693CrossRef
38.
Zurück zum Zitat Lee SS, Ryu SW, Kim IH et al (2012) Quality of life beyond the early postoperative period after laparoscopy-assisted distal gastrectomy: the level of patient expectation as the essence of quality of life. Gastric Cancer 3:299–304CrossRef Lee SS, Ryu SW, Kim IH et al (2012) Quality of life beyond the early postoperative period after laparoscopy-assisted distal gastrectomy: the level of patient expectation as the essence of quality of life. Gastric Cancer 3:299–304CrossRef
39.
Zurück zum Zitat Sullivan M, Tanzer M, Reardon G et al (2011) The role of presurgical expectancies in predicting pain and function one year following total knee arthroplasty. Pain 10:2287–2293CrossRef Sullivan M, Tanzer M, Reardon G et al (2011) The role of presurgical expectancies in predicting pain and function one year following total knee arthroplasty. Pain 10:2287–2293CrossRef
40.
Zurück zum Zitat Gutschow CA, Hölscher AH, Leers J et al (2013) Health-related quality of life after Ivor Lewis esophagectomy. Langenbecks Arch Surg 398(2):231–237PubMedCrossRef Gutschow CA, Hölscher AH, Leers J et al (2013) Health-related quality of life after Ivor Lewis esophagectomy. Langenbecks Arch Surg 398(2):231–237PubMedCrossRef
41.
Zurück zum Zitat Herrero LA, van Vilsteren FGI, Pouw RE et al (2011) Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett’s esophagus longer than 10 cm. Gastrointest Endosc 4:682–690CrossRef Herrero LA, van Vilsteren FGI, Pouw RE et al (2011) Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett’s esophagus longer than 10 cm. Gastrointest Endosc 4:682–690CrossRef
42.
Zurück zum Zitat Pech O, Behrens A, May A et al (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 9:1200–1206CrossRef Pech O, Behrens A, May A et al (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 9:1200–1206CrossRef
43.
Zurück zum Zitat Hölscher AH, Vallböhmer D, Gutschow C et al (2009) Reflux esophagitis, high-grade neoplasia, and early Barrett’s carcinoma: what is the place of the Merendino procedure? Langenbecks Arch Surg 3:417–424CrossRef Hölscher AH, Vallböhmer D, Gutschow C et al (2009) Reflux esophagitis, high-grade neoplasia, and early Barrett’s carcinoma: what is the place of the Merendino procedure? Langenbecks Arch Surg 3:417–424CrossRef
Metadaten
Titel
Quality of Life After Surgical Treatment of Early Barrett’s Cancer: A Prospective Comparison of the Ivor-Lewis Resection Versus the Modified Merendino Resection
verfasst von
Ch. Zapletal
Ch. Heesen
J. Origer
M. Pauthner
O. Pech
Ch. Ell
Dietmar Lorenz
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
World Journal of Surgery / Ausgabe 6/2014
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-013-2410-1

Weitere Artikel der Ausgabe 6/2014

World Journal of Surgery 6/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.